-
PMLiVE’s T40 – open for submissions!
Source: Pharmafile Published on 2024-03-28
-
Abenza announces investment in bioconjugation and ADC capabilities
Source: Pharmafile Published on 2024-03-28
-
Provectus Biopharmaceuticals announces license agreement with University of Miami
Source: Pharmafile Published on 2024-03-28
-
FDA approves Merck’s Winrevair for PAH treatment
Source: Pharmafile Published on 2024-03-27
-
Heidelberg Pharma gains FDA ODD for ATAC candidate
Source: Pharmafile Published on 2024-03-27
-
Curve Therapeutics publishes research on HIF inhibition for cancer treatment
Source: Pharmafile Published on 2024-03-26
-
AbbVie to acquire Landos Biopharma for approximately $137.5m
Source: Pharmafile Published on 2024-03-26
-
FDA approves AstraZeneca’s Ultomiris for NMOSD treatment
Source: Pharmafile Published on 2024-03-25
-
FDA approves J&J’s Opsynvi for PAH treatment
Source: Pharmafile Published on 2024-03-25
-
FDA approves Idorsia’s Tryvio for treatment of high blood pressure
Source: Pharmafile Published on 2024-03-22
-
CHMP recommends Novo Nordisk’s Awiqli for diabetes treatment
Source: Pharmafile Published on 2024-03-22
-
MHRA approves Takeda’s Hyqvia for chronic inflammatory demyelinating polyneuropathy treatment
Source: Pharmafile Published on 2024-03-21
-
Sosei Heptares doses first patient in trial for inflammatory bowel disease treatment
Source: Pharmafile Published on 2024-03-21
-
Boehringer Ingelheim’s Spevigo gains additional approvals in US and China
Source: Pharmafile Published on 2024-03-20
-
Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn
Source: Pharmafile Published on 2024-03-20